Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carmustine | 1 | 2008 | 11 | 0.270 |
Why?
|
| Lymphoma, T-Cell | 1 | 2008 | 23 | 0.270 |
Why?
|
| Pleural Effusion | 1 | 2008 | 39 | 0.270 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 22 | 0.270 |
Why?
|
| Androstadienes | 1 | 2008 | 43 | 0.270 |
Why?
|
| Adenocarcinoma | 2 | 2008 | 364 | 0.230 |
Why?
|
| Cecal Neoplasms | 1 | 2005 | 2 | 0.230 |
Why?
|
| Intussusception | 1 | 2005 | 16 | 0.220 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 57 | 0.210 |
Why?
|
| Catheters, Indwelling | 1 | 2005 | 67 | 0.210 |
Why?
|
| Catheterization, Central Venous | 1 | 2005 | 84 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 464 | 0.200 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2003 | 2 | 0.200 |
Why?
|
| Neurilemmoma | 1 | 2003 | 11 | 0.200 |
Why?
|
| Muscle Neoplasms | 1 | 2003 | 9 | 0.200 |
Why?
|
| Psoas Muscles | 1 | 2003 | 12 | 0.200 |
Why?
|
| Back Pain | 1 | 2003 | 49 | 0.190 |
Why?
|
| Abdominal Pain | 1 | 2003 | 98 | 0.190 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 318 | 0.180 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 1222 | 0.120 |
Why?
|
| Colonic Neoplasms | 2 | 2008 | 220 | 0.120 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 991 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2008 | 1656 | 0.080 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2008 | 3 | 0.070 |
Why?
|
| Fluticasone | 1 | 2008 | 17 | 0.070 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2008 | 33 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 79 | 0.070 |
Why?
|
| Streptococcus bovis | 1 | 2007 | 4 | 0.060 |
Why?
|
| Eye Infections, Bacterial | 1 | 2007 | 11 | 0.060 |
Why?
|
| Endophthalmitis | 1 | 2007 | 16 | 0.060 |
Why?
|
| Streptococcal Infections | 1 | 2007 | 84 | 0.060 |
Why?
|
| Bacteremia | 1 | 2007 | 91 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2007 | 157 | 0.060 |
Why?
|
| Cecal Diseases | 1 | 2005 | 4 | 0.060 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 142 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 308 | 0.060 |
Why?
|
| Subclavian Vein | 1 | 2005 | 13 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2005 | 63 | 0.050 |
Why?
|
| Syndrome | 1 | 2005 | 180 | 0.050 |
Why?
|
| Echocardiography | 1 | 2008 | 510 | 0.050 |
Why?
|
| Device Removal | 1 | 2005 | 64 | 0.050 |
Why?
|
| Colectomy | 1 | 2005 | 123 | 0.050 |
Why?
|
| Femoral Neuropathy | 1 | 2003 | 2 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 875 | 0.050 |
Why?
|
| Femoral Nerve | 1 | 2003 | 10 | 0.050 |
Why?
|
| Spinal Nerve Roots | 1 | 2003 | 18 | 0.050 |
Why?
|
| Laminectomy | 1 | 2003 | 26 | 0.050 |
Why?
|
| Radiography | 1 | 2005 | 555 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 643 | 0.050 |
Why?
|
| Liver | 1 | 2007 | 871 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 178 | 0.040 |
Why?
|
| Humans | 7 | 2008 | 65140 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 272 | 0.040 |
Why?
|
| Female | 3 | 2008 | 34018 | 0.040 |
Why?
|
| Adult | 2 | 2008 | 17358 | 0.040 |
Why?
|
| Middle Aged | 3 | 2008 | 18273 | 0.040 |
Why?
|
| Male | 3 | 2008 | 31047 | 0.020 |
Why?
|
| Cetuximab | 1 | 2008 | 8 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2007 | 38 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2007 | 31 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2007 | 97 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2007 | 53 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2008 | 250 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 844 | 0.010 |
Why?
|
| Incidence | 1 | 2007 | 1419 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 2244 | 0.010 |
Why?
|
| United States | 1 | 2007 | 8093 | 0.010 |
Why?
|
| Aged | 1 | 2007 | 14965 | 0.010 |
Why?
|